Pfizer, maker of the most widely-used COVID-19 vaccine in the U.S., is evaluating a prospective pill-based treatment for the infection utilizing the same class of medication usually used to deal with HIV.
Pfizer announced the beginning of a stage 1 medical trial using a protease inhibitor pill as a treatment for the infection on Tuesday.
Spencer Platt/Getty
Dolsten promoted both the oral medication and the business’s previously-developed experimental protease inhibitor treatment designed to be administered to hospitalized COVID-19 patients intravenously, which is currently undergoing phase 1b trials.
While none of the vaccines offer overall defense against contracting the virus, they have actually been shown to substantially reduce infections and to be incredibly effective in avoiding hospitalizations and death.
As of Tuesday, over 64.6 million individuals in the U.S. had actually gotten at least one dosage of the Pfizer-BioNTech vaccine, according to the Centers for Illness Control and Prevention.
Protease inhibitors, which obstruct infection recreation by binding to proteins called protease, were a class of drugs that transformed HIV treatment in the mid-1990 s. The drugs are likewise used versus Hepatitis C infections, while scientists have actually investigated their usage as treatments for particular types of cancer and parasitic infections.
http://criminaljusticecourses.net/pfizer-screening-covid-treatment-pill-that-utilizes-same-innovation-common-in-treating-hiv/
No comments:
Post a Comment